Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

Development of the 4-component meningococcal serogroup B vaccine (4CMenB) has required new assays for the reliable evaluation of the expression and cross-reactivity of those specific antigen variants that are predicted to be targeted by bactericidal antibodies elicited by the vaccine in different is...

Descripción completa

Detalles Bibliográficos
Autores principales: Domnich, Alexander, Gasparini, Roberto, Amicizia, Daniela, Boccadifuoco, Giuseppe, Giuliani, Marzia Monica, Panatto, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553328/
https://www.ncbi.nlm.nih.gov/pubmed/26351645
http://dx.doi.org/10.1155/2015/353461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553328/
https://www.ncbi.nlm.nih.gov/pubmed/26351645
http://dx.doi.org/10.1155/2015/353461

Ejemplares similares